IE
IE · IE · IE-PA-EU/1/14/945/009-010
IMBRUVICA 280 mg film-coated tablets
ATC L01XE27
Last synced from HPRA (Ireland) on
Identification
ManufacturerJanssen-Cilag International NV
CountryIE (IE)
ATC codeL01XE27
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/14/945/009-010
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L01XE27"
],
"strength": null,
"pa_number": "EU/1/14/945/009-010",
"substances": [
"Ibrutinib"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code L01XE27.
- BEImbruvica 140 mgJanssen-Cilag International
- IEIMBRUVICA 140 mg film-coated tabletsJanssen-Cilag International NV
- IEIMBRUVICA 140 mg hard capsulesJanssen-Cilag International NV
- BEImbruvica 280 mgJanssen-Cilag International
- IEIMBRUVICA 420 mg film-coated tabletsJanssen-Cilag International NV
- IEIMBRUVICA 560 mg film-coated tabletsJanssen-Cilag International NV
Access this data programmatically
Query IMBRUVICA 280 mg film-coated tablets and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.